Gastroenterology Information Center

Proton pump inhibitor use may decrease healthcare visits in GERD patients

Proton pump inhibitor use may decrease healthcare visits in GERD patients

Among GERD patients, the mean annual ARI episode dropped from 4.39 during the year before PPI treatment to 3.89 after treatment with a PPI.

News FDA approves Trulance for chronic idiopathic constipation treatment

FDA approves Trulance for chronic idiopathic constipation treatment

Trulance has been approved for the treatment of chronic idiopathic constipation in adults.

Healthday Endoscopic sleeve gastroplasty results in successful weight loss

Endoscopic sleeve gastroplasty results in successful weight loss

The procedure could be used as alternative to bariatric surgery for selected patients with obesity.

Healthday HCV patients with diabetes may have increased risk of hepatocellular carcinoma

HCV patients with diabetes may have increased risk of hepatocellular carcinoma

Diabetes could increase the risk of developing hepatocellular carcinoma in patients with hepatitis C.

Healthday Gastrointestinal adverse events increase with GLP-1 receptor agonists

Gastrointestinal adverse events increase with GLP-1 receptor agonists

Risk was dependent on dose, background medications, and type of GLP-1 receptor agonist.

Healthday Antibiotics associated with reduced mortality rate in cirrhosis patients

Antibiotics associated with reduced mortality rate in cirrhosis patients

Timely administration of antibiotics was associated with a 30% reduction in 30 day mortality.

Healthday Liver hepatotoxicity results from herbal, dietary supplements

Liver hepatotoxicity results from herbal, dietary supplements

The ultimate goal should be to more closely regulate potentially injurious ingredients in herbal and dietary supplements.

News FDA requires black box warning on HCV drugs regarding potential HBV reactivation

FDA requires black box warning on HCV drugs regarding potential HBV reactivation

The FDA issues a warning about the risk of hepatitis B virus reactivation among patients taking direct-acting antivirals to treat hepatitis C infections.

Healthday Biologic agents may increase infection risk in inflammatory bowel disease

Biologic agents may increase infection risk in inflammatory bowel disease

Biologic agents increase the risk of opportunistic infection, but do not increase the risk of serious infection or malignancy.

Healthday Exercise reduces lipid content in nonalcoholic fatty liver disease

Exercise reduces lipid content in nonalcoholic fatty liver disease

Physical Activity reduces intrahepatic lipid content and markers of hepatocellular injury in patients with NAFLD and this effect correlated with baseline body mass index.

Sign Up for Free e-newsletters